EN
HI
Marksans Pharma Share price
MARKSANS
182.19
1.90 (1.05%)NSE
BSE
Last updated on 2 Jan, 2026 | 15:49 IST
BUYSELL
Today's High
184.23
Today's Low
179.49
52 Week Low
162.00
52 Week High
308.00
The current prices are delayed, login to your account for live prices
Login Marksans Pharma Chart
Marksans Pharma Share Key Metrics
Volume
5.14 L
Market Cap
8258.46 CR
LTQ@LTP
193@182.19
ATP
182.05
Var Margin
21.24 %
Circuit Range
144.24-216.34
Delivery %
47.79 %
Value
9.35 CR
ASM/GSM
No
Market Lot
1
Summary
At 2 Jan, 2026 | 15:49, Marksans Pharma share price stands at ₹182.19, showing a 1.90% 1.05 for the day. The stock’s intraday movement has stayed between ₹179.49 and ₹184.23, while on a 52-week basis it has fluctuated from ₹162.00 to ₹308.00.
In terms of trading activity, Marksans Pharma has recorded a volume of 513504 shares, with a market capitalisation of ₹453288438. The stock’s Average Traded Price (ATP) stands at ₹18205, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 193,18219. The stock operates within a circuit range of ₹144.24-216.34, with a Value of ₹9.35 CR. The Delivery Percentage for the day is 47.79%. Additionally, Marksans Pharma currently falls under the No framework, and trades with a market lot size of 1.
Marksans Pharma Fundamentals
View MoreP/E Ratio
23.16
P/B Ratio
3.03
Div. Yield
0.45
Sector P/E
70.76
Sector P/B
1.03
Sec. Div. Yield
0.56
Marksans Pharma Resistance and Support
Pivot 248.68
Resistance
First Resistance
255.26
Second Resistance
262.58
Third Resistance
269.16
Support
First Support
241.36
Second Support
234.78
Third Support
227.46
Marksans Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2025-11-13 | Quarterly Results |
| 2025-08-12 | Quarterly Results |
| 2025-05-19 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results |
Marksans Pharma News
Marksans Pharma stock skyrockets 13% on strong all-round Q1 earnings show
Aug 14 2024 12:31:54
Read More
About Marksans Pharma
NSE : 10579
BSE : 524404
ISIN : INE750C01026
Marksans Pharma Management
| Name | Position |
|---|---|
| Mr. Mark Saldanha | Chairman & Managing Director |
| Mrs. Sandra Saldanha | Whole Time Director |
Marksans Pharma Similar Stocks
Jupiter Life Line Hospitals Ltd.
1405.00
11.60 (0.83%)
Blue Jet Healthcare Ltd.
531.10
0.90 (0.17%)
Procter & Gamble Health Ltd.
5701.50
-1.50 (0.03%)
CORONA Remedies Ltd.
1443.50
58.60 (4.23%)
Strides Pharma Science Ltd.
900.75
0.40 (0.04%)
Thyrocare Technologies Ltd.
459.20
13.50 (3.03%)
Akums Drugs & Pharmaceuticals Ltd.
451.85
-1.55 (0.34%)
Sudeep Pharma Ltd.
596.80
-5.95 (0.99%)
Aarti Pharmalabs Ltd.
742.10
-10.30 (1.37%)
FDC Ltd.
419.55
-3.55 (0.84%)
Marksans Pharma FAQs
The Buying Price of Marksans Pharma share is 182.19 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Marksans Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Marksans Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Marksans Pharma shares is 23.16. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Marksans Pharma shares is 3.03. Useful to assess the stock's value relative to its book value.
To assess Marksans Pharma’s valuation compare Sector P/E, P/B which are 70.76 & 1.03 with sector averages, along with growth rates and financial metrics.
The Market Cap of Marksans Pharma is 8258.46 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Marksans Pharma share price is 308.00 & 162.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Marksans Pharma belongs to the Healthcare sector.